Gastroenterology Practice Questions

Q: A 40-year-old male with gastroesophageal reflux disease (GERD) is found to have Barrett's esophagus with low-grade dysplasia on endoscopy. What is the most appropriate initial pharmacological treatment for this condition?

PPI. ***PPI*** - In patients with **GERD** and **low-grade dysplasia**, high-dose **proton pump inhibitors (PPIs)** are the initial treatment of choice to suppress acid reflux. - Continuous acid suppression can help in the regression of dysplasia and prevent its progression to higher grades. *Fundoplication* - **Fundoplication** is a surgical procedure to treat severe GERD, but it is not the primary initial treatment for low-grade dysplasia. - It might be considered if medical therapy with PPIs fails or if there are significant anatomical defects. *Esophageal resection* - **Esophageal resection** is a major surgical procedure typically reserved for **high-grade dysplasia** or **esophageal adenocarcinoma**. - It is an overly aggressive and unnecessary intervention for initial management of low-grade dysplasia. *Diet modification* - **Diet modification** is an important adjunctive therapy for GERD symptoms and overall gastric health. - However, it is generally insufficient as a standalone initial treatment for documented **low-grade dysplasia** without concurrent pharmacotherapy.

Q: Extraintestinal manifestations of Inflammatory bowel disease include all of the following, Except:

Osteoarthritis. ***Osteoarthritis*** - **Osteoarthritis** is a **degenerative joint disease** caused by wear and tear on cartilage, and it is **not** an extraintestinal manifestation of IBD [3]. - While patients with IBD can develop osteoarthritis, it does not share the same **pathophysiological link** to the inflammatory process of IBD as other extraintestinal manifestations. *Uveitis* - **Uveitis** is an inflammation of the **uvea** (middle layer of the eye) and is a well-recognized ocular extraintestinal manifestation of IBD [2]. - It can cause eye pain, redness, and blurred vision, and its severity may correlate with IBD disease activity. *Sclerosing cholangitis* - **Primary sclerosing cholangitis (PSC)** is a chronic cholestatic liver disease characterized by inflammation and fibrosis of the **bile ducts**, and it is strongly associated with **ulcerative colitis** [1]. - It often progresses to **cirrhosis** and liver failure and is a significant extraintestinal manifestation. *Skin nodules* - **Erythema nodosum** and **pyoderma gangrenosum** are common cutaneous extraintestinal manifestations of IBD, often presenting as **painful red nodules** or ulcers on the skin [2]. - These skin conditions are thought to be immune-mediated and often parallel the activity of the underlying inflammatory bowel disease.

Q: Which of the following is not a recognized complication of chronic pancreatitis?

Renal artery thrombosis. ***Renal artery thrombosis*** - **Renal artery thrombosis** is generally associated with conditions like **atherosclerosis**, atrial fibrillation, or vasculitis, not directly with chronic pancreatitis. - While chronic pancreatitis can lead to systemic complications, direct renal arterial clotting is an atypical and **uncommon sequela**. *Pancreatic pseudocyst* - **Pancreatic pseudocysts** are common complications of chronic pancreatitis, occurring when fluid collections around the pancreas become walled off by fibrous tissue [1]. - They can cause pain, obstruction, and even rupture if left untreated [2]. *Splenic vein thrombosis* - **Splenic vein thrombosis** can result from inflammation and compression of the splenic vein by the diseased pancreatic tissue in chronic pancreatitis [1]. - This can lead to **splenomegaly** and **gastric varices** due to increased pressure in the portal system. *Pancreatic fistula* - A **pancreatic fistula** occurs when pancreatic fluid leaks from the gland, often forming a connection to another organ or the skin [2]. - This is a well-recognized complication of both acute and chronic pancreatitis, usually due to ductal disruption.

Q: All of the following are features of Obstructive jaundice except:

Normal alkaline phosphatase. ***Normal alkaline phosphatase*** - In obstructive jaundice, alkaline phosphatase is typically **elevated** due to bile duct obstruction [2]. - A **normal level** suggests that the jaundice may not be of obstructive origin. *Pruritis* - Often seen in obstructive jaundice due to **bile salts** accumulating in the bloodstream, leading to itching. - It is a common symptom associated with **cholestasis**. *Mildly elevated serum aminotransferases level* - In obstructive jaundice, serum aminotransferases are usually elevated, though may be mildly in early cases [1]. - This reflects liver involvement, which is consistent with biliary obstruction [2]. *Clay colour stools* - Clay-colored stools arise from the absence of **bile** in the intestines, indicative of obstruction [3]. - This is a direct result of blockage in the bile duct system affecting stool pigmentation [3].

Q: Where is Schatzki's Ring present?

Lower end of esophagus. ***Lower end of esophagus*** - **Schatzki's Ring** is a localized narrowing that can occur at the **gastroesophageal junction**, specifically at the squamocolumnar junction. - This ring is a common cause of intermittent **dysphagia** for solid foods. [2] *Upper end of trachea* - The upper end of the trachea is the **larynx** or a region just below it, which is anatomically distinct from the esophagus. - Constrictions in this area are generally unrelated to Schatzki's Ring and typically involve conditions like **subglottic stenosis**. *Upper end of esophagus* - The upper end of the esophagus contains the **upper esophageal sphincter** (UES), which is a muscular structure. [3] - While strictures can occur here, they are not referred to as Schatzki's Ring. *Lower end of trachea* - The lower end of the trachea **bifurcates into the bronchi** and is part of the respiratory system. [1] - Anatomically, it is separate from the esophagus, and issues here would be related to respiratory conditions, not Schatzki's Ring.

Q: Genitourinary complication of ulcerative colitis

Urinary calculi. ***Urinary calculi*** - Patients with ulcerative colitis are at an increased risk of developing **urinary calculi** due to several factors, including chronic dehydration, malabsorption of fats leading to increased oxalate absorption (enteric hyperoxaluria), and altered urine composition. - The inflammatory process and potential for surgical interventions (e.g., colectomy with ileostomy) can further predispose individuals to kidney stone formation. *Cystitis* - While cystitis (bladder inflammation) can occur in the general population, it is not considered a specific or significantly elevated genitourinary complication directly linked to the pathogenesis of ulcerative colitis itself. - It results primarily from bacterial infection, and there is no direct evidence suggesting UC patients have a higher intrinsic risk compared to the general population. *Pyelonephritis* - Pyelonephritis (kidney infection) is not a direct or common complication of ulcerative colitis. - It is typically caused by bacterial ascent from the lower urinary tract and is not specifically promoted by the inflammatory processes or metabolic changes associated with UC. *Urethritis* - Urethritis (inflammation of the urethra) is primarily associated with sexually transmitted infections or irritation and is not a recognized genitourinary complication directly caused by ulcerative colitis. - There is no increased incidence of urethritis in UC patients compared to the general population.

Q: What is the drug of choice for bleeding oesophageal varices?

Octreotide. ***Octreotide*** - **Octreotide** is an analogue of **somatostatin** that reduces splanchnic blood flow and portal pressure, thereby decreasing bleeding from esophageal varices. - It is often used in the acute management of **bleeding esophageal varices** due to its rapid onset of action and favorable safety profile. *Ethanolamine oleate* - **Ethanolamine oleate** is a **sclerosing agent** used for endoscopic sclerotherapy of esophageal varices, not typically as the initial drug of choice for acute bleeding [1]. - It acts by causing inflammation and fibrosis of the varices, which can be effective but carries risks such as **esophageal ulceration** or perforation. *Propranolol* - **Propranolol** is a **non-selective beta-blocker** used for the prophylactic prevention of variceal bleeding, not for acute management of active bleeding. - It works by reducing portal venous pressure by decreasing cardiac output and splanchnic vasoconstriction. *Phytonadione* - **Phytonadione** (vitamin K1) is used to reverse **coumarin anticoagulant effects** or to treat **vitamin K deficiency**, which can contribute to bleeding but is not a direct treatment for variceal bleeding itself. - It helps in the synthesis of **coagulation factors II, VII, IX, and X**, thereby improving clotting.

Q: What is the most common location of gastrinoma?

Duodenum. ***Duodenum*** - The **duodenum** is the most common site for gastrinomas, accounting for over **half of all cases**, particularly in sporadic gastrinoma and Zollinger-Ellison syndrome. - These tumors are often **small** and **multiple** in the duodenum, making them challenging to locate. *Pancreas* - Pancreatic gastrinomas are also common, representing approximately **25-40% of cases**, but are less frequent than duodenal gastrinomas. - Pancreatic gastrinomas tend to be **larger** and more amenable to surgical resection when compared to duodenal gastrinomas. *Jejunum* - Gastrinomas found in the jejunum are **rare**, accounting for only a small percentage of cases. - The small intestine distal to the duodenum is an **uncommon site** for primary gastrinoma formation. *Gall bladder* - The **gallbladder** is not a typical location for gastrinoma development. - Gastrinomas are neuroendocrine tumors that arise from **gastrin-producing cells**, which are not found in the gallbladder.

Q: Which of the following statements about Gilbert syndrome is false?

Causes cirrhosis. ***Causes cirrhosis*** - **Gilbert syndrome** is a benign condition characterized by intermittent unconjugated hyperbilirubinemia and does **not lead to cirrhosis** [1]. - Cirrhosis is a severe form of **liver scarring** resulting from chronic damage, which is not a feature of Gilbert syndrome. *Normal liver histology* - The liver structure and function in individuals with Gilbert syndrome are typically **normal**, distinguishing it from other liver disorders [2]. - Histological examination of liver biopsies usually reveals no abnormalities, reflecting the **benign nature** of the condition. *Autosomal dominant* - Gilbert syndrome is inherited in an **autosomal recessive** pattern, not autosomal dominant [2]. - It results from a reduction in the activity of the **UGT1A1 enzyme**, which is responsible for bilirubin conjugation [1], [2]. *Elevated bilirubin levels are present* - Individuals with Gilbert syndrome experience **intermittent unconjugated hyperbilirubinemia**, meaning their indirect bilirubin levels are elevated [3]. - This elevation is usually mild and can be exacerbated by stress, fasting, or illness, but it is typically **harmless** [1], [2].

Q: The most classical symptom of VIPOMA is:

Secretory diarrhea. The original text cannot be accurately enriched with the provided references to because none of the source materials directly address the pathophysiology or clinical presentation of VIPoma. The available references focus on general gastroenteropancreatic neuroendocrine tumors (NETs) , radiation-induced intestinal damage , arsenic poisoning , gastrointestinal bleeding , and the physiology of taste , but they do not provide the specific confirmation needed for the 'classical symptom' of VIPoma (secretory diarrhea).

Question 1

A 40-year-old male with gastroesophageal reflux disease (GERD) is found to have Barrett's esophagus with low-grade dysplasia on endoscopy. What is the most appropriate initial pharmacological treatment for this condition?

Accepted Answer

PPI

Answer

Fundoplication

Answer

Esophageal resection

Answer

Diet modification

Question 2

Extraintestinal manifestations of Inflammatory bowel disease include all of the following, Except:

Accepted Answer

Osteoarthritis

Answer

Sclerosing cholangitis

Answer

Skin nodules

Answer

Uveitis

Question 3

Which of the following is not a recognized complication of chronic pancreatitis?

Accepted Answer

Renal artery thrombosis

Answer

Pancreatic pseudocyst

Answer

Splenic vein thrombosis

Answer

Pancreatic fistula

Question 4

All of the following are features of Obstructive jaundice except:

Accepted Answer

Normal alkaline phosphatase

Answer

Clay colour stools

Answer

Pruritis

Answer

Elevated serum aminotransferases level

Question 5

Where is Schatzki's Ring present?

Accepted Answer

Lower end of esophagus

Answer

Upper end of trachea

Answer

Upper end of esophagus

Answer

Lower end of trachea

Question 6

Genitourinary complication of ulcerative colitis

Accepted Answer

Urinary calculi

Answer

Pyelonephritis

Answer

Urethritis

Answer

Cystitis

Question 7

What is the drug of choice for bleeding oesophageal varices?

Accepted Answer

Octreotide

Answer

Ethanolamine oleate

Answer

Propanolol

Answer

Phytonadione

Question 8

What is the most common location of gastrinoma?

Accepted Answer

Duodenum

Answer

Pancreas

Answer

Jejunum

Answer

Gall bladder

Question 9

Which of the following statements about Gilbert syndrome is false?

Accepted Answer

Causes cirrhosis

Answer

Normal liver histology

Answer

Autosomal dominant

Answer

Elevated bilirubin levels are present

Question 10

The most classical symptom of VIPOMA is:

Accepted Answer

Secretory diarrhea

Answer

Gall stones

Answer

Steatorrhea

Answer

Flushing

Gastroenterology — MCQs

Gastroenterology — MCQs

On this page

Practice by Chapter

Want unlimited practice?